Search results for: Bernarda Zamora
Filter search results
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…reasonable rate of return. Download the full report here. Related Research Zamora, B., Garau, M., Maignen, F., O’Neill, P., & Mestre-Ferrandiz, J. (2017). Access to Orphan Medicinal Products…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…Economics. RePEc. Towse, A., Cole, A. and Zamora, B., 2018. The Debate on Indication-Based Pricing in the US and Five Major European Countries. OHE Consulting Report. London: Office of Health…
OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018
5 November 2018
…to the “Affordability Issue”. Value in Health, 21(3), pp.76-279. DOI: https://doi.org/10.1016/j.jval.2017.12.013. Towse, A., Cole, A., and Zamora, B. (2018). The Debate on Indication-Based Pricing in the U.S. and Five…
Adrian Towse named 2018 Value Assessment Challenge Award Recipient
22 October 2018
…in precision cancer medicine. Journal of Cancer Policy, 11, pp.48-53. Garrison L., Mestre-Ferrandiz J, Zamora B. The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of…